CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-18 | GRIFFIN MICHELLE RENEE Director | Option exercise · Stock Option (Right to Buy) | −2,500 | 76,000 | ||
| 2021-05-18 | Palaniappan Jyoti SVP, Diagnostics, T-Detect | Option exercise | +651 | $22.55 | $15K | 9,809 |
| 2021-05-18 | Palaniappan Jyoti SVP, Diagnostics, T-Detect | Sale | −651 | $35.00 | $23K | 9,158 |
| 2021-05-18 | Palaniappan Jyoti SVP, Diagnostics, T-Detect | Option exercise · Stock Option (Right to Buy) | −651 | 106,996 | ||
| 2021-05-17 | THORSEN HENNING SVP, Commercial Operations | Grant or award | +29,061 | 29,061 | ||
| 2021-05-17 | THORSEN HENNING SVP, Commercial Operations | Grant or award · Stock Option (Right to Buy) | +72,653 | 72,653 | ||
| 2021-05-14 | LO FRANCIS Chief People Officer | Option exercise | +2,000 | $7.80 | $16K | 22,604 |
| 2021-05-14 | LO FRANCIS Chief People Officer | Sale | −2,000 | $33.80 | $68K | 20,604 |
| 2021-05-14 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (Right To Buy) | −2,000 | 151,000 | ||
| 2021-05-12 | Cohen Chad M Chief Financial Officer | Option exercise | +10,000 | $6.55 | $66K | 31,604 |
| 2021-05-12 | Cohen Chad M Chief Financial Officer | Sale | −10,000 | $32.63 | $326K | 21,604 |
| 2021-05-12 | Cohen Chad M Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 130,000 | ||
| 2021-05-11 | Cohen Chad M Chief Financial Officer | Option exercise | +10,000 | $6.55 | $66K | 31,604 |
| 2021-05-11 | Cohen Chad M Chief Financial Officer | Sale | −2,969 | $30.81 | $91K | 28,635 |
| 2021-05-11 | Cohen Chad M Chief Financial Officer | Sale | −7,031 | $31.84 | $224K | 21,604 |
| 2021-05-11 | Cohen Chad M Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 140,000 | ||
| 2021-05-06 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-05-06 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,048 | $35.51 | $108K | 70,207 |
| 2021-05-06 | ROBINS HARLAN S Chief Scientific Officer | Sale | −847 | $36.38 | $31K | 69,360 |
| 2021-05-06 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 128,535 |
Page 47 of 120 · 2,386 trades